Allakos

Traded on the St. Petersburg Stock Exchange
Allakos is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases.
Allakos stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Allakos balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Allakos cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Allakos multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Allakos profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Allakos assets
Allakos cash flows

Allakos shares

TickerNameTypeNominal valueISINPrice
ALLK:USAllakos, Inc.Common share-US01671P1003$1.38
Allakos news
09.05.2022
Allakos' GAAP loss for 3 months of 2022 was $197.023 million, up 3.5 times from $55.558 million in the previous year.
Source: investor.allakos.com pictogram investor.allakos.com
Pictogram next
02.03.2022
Allakos' GAAP loss for 2021 was $269.86 million, up 75.8% from $153.48 million in the previous year.
Source: investor.allakos.com pictogram investor.allakos.com
Pictogram next
09.11.2021
Allakos' GAAP loss for 9M 2021 was $175.496 million, up 60.7% from $109.202 million in the previous year.
Source: investor.allakos.com pictogram investor.allakos.com
Pictogram next
10.08.2021
Allakos' GAAP loss for 6M 2021 was $112.767 million, up 68% from $67.116 million in the previous year.
Source: investor.allakos.com pictogram investor.allakos.com
Pictogram next
All Allakos news
General information
Company nameAllakos
Tags#biotechnology
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Mailing address975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Websitewww.allakos.com
Information disclosurewww.sec.gov